Per HIF-α/VEGF pathway, PAR-1 maintains self-renewal and tumorigenicity of tumor-initiating progenitor cells (TPC) in gliomas, whilst inhibition of PAR-1 signaling slows down tumor progression [113–114]. The gene discussed is VEGFA; the disease is neoplasm.